UCB BIOPHARMA SPRL has a total of 1,520 patent applications. It decreased the IP activity by 22.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are MEDAREX INC, BEIJING HANMI PHARMACEUTICAL CO LTD and IMCLONE SYSTEMS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 200 | |
#2 | United States | 171 | |
#3 | WIPO (World Intellectual Property Organization) | 160 | |
#4 | United Kingdom | 131 | |
#5 | Canada | 117 | |
#6 | China | 107 | |
#7 | Brazil | 67 | |
#8 | Mexico | 51 | |
#9 | Australia | 48 | |
#10 | Republic of Korea | 47 | |
#11 | Chile | 44 | |
#12 | Israel | 42 | |
#13 | Singapore | 37 | |
#14 | Hungary | 36 | |
#15 | Argentina | 32 | |
#16 | Russian Federation | 27 | |
#17 | Colombia | 25 | |
#18 | EAPO (Eurasian Patent Organization) | 22 | |
#19 | Serbia | 21 | |
#20 | Taiwan | 20 | |
#21 | Uruguay | 16 | |
#22 | Montenegro | 15 | |
#23 | Japan | 11 | |
#24 | Peru | 11 | |
#25 | Hong Kong | 9 | |
#26 | Philippines | 8 | |
#27 | Morocco | 7 | |
#28 | Ecuador | 6 | |
#29 | Slovenia | 6 | |
#30 | Tunisia | 6 | |
#31 | South Africa | 6 | |
#32 | Ukraine | 3 | |
#33 | African Regional Industrial Property Organization | 2 | |
#34 | Belgium | 1 | |
#35 | Costa Rica | 1 | |
#36 | Guatemala | 1 | |
#37 | India | 1 | |
#38 | Lithuania | 1 | |
#39 | Malaysia | 1 | |
#40 | Netherlands | 1 | |
#41 | Norway | 1 | |
#42 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Analysing materials | |
#6 | Microorganisms | |
#7 | Fermentation | |
#8 | Syringes | |
#9 | Organic chemistry methods | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Humphreys David Paul | 143 |
#2 | Tyson Kerry Louise | 115 |
#3 | Heywood Sam Philip | 107 |
#4 | Kroeplien Boris | 99 |
#5 | Porter John Robert | 98 |
#6 | Adams Ralph | 95 |
#7 | Rapecki Stephen Edward | 90 |
#8 | Finney Helene Margaret | 89 |
#9 | Jackson Victoria Elizabeth | 87 |
#10 | Wright Michael John | 87 |
Publication | Filing date | Title |
---|---|---|
GB202019702D0 | Therapeutic agents | |
GB202012991D0 | Cell culture processes | |
GB202012501D0 | Therapeutic agents | |
GB202010606D0 | Therapeutic agents | |
GB202010607D0 | Therapeutic agents | |
GB202004462D0 | Antibody fragments | |
GB202001447D0 | Antibodies | |
GB201919213D0 | Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds | |
GB201919214D0 | Tetrahydrobenzo-quinoline sulfonamide derivatives useful as IGE modulators | |
GB201919212D0 | Dihydro-cyclopenta-isoquinoline sulfonamides derivatives | |
GB201919061D0 | Multi-specific antibody | |
GB201919062D0 | Antibody | |
GB201919058D0 | Multi-specific antibodies | |
GB201913759D0 | Therapeutic agents | |
GB201911865D0 | Therapeutic agents | |
GB201909191D0 | Therapeutic agents | |
GB201909194D0 | Therapeutic agents | |
GB201909190D0 | Therapeutic agents | |
WO2019226753A1 | Benzodiazepine formulations | |
GB201906835D0 | Dry microparticles |